Cargando…
32329 A novel mouse model of Ataxia Telangiectasia for testing small molecule readthrough compounds
ABSTRACT IMPACT: Small molecule readthrough compounds are a promising therapeutic with the potential to overcome nonsense mutations thereby enabling the production of functional ATM protein in patients with Ataxia Telangiectasia OBJECTIVES/GOALS: To generate a novel mouse model of Ataxia-Telangiecta...
Autor principal: | Mathews, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827764/ http://dx.doi.org/10.1017/cts.2021.430 |
Ejemplares similares
-
ATAXIA TELANGIECTASIA MUTATED PROTECTS AGAINST LIPOPOLYSACCARIDE-INDUCED BLOOD-BRAIN BARRIER DISRUPTION BY REGULATING ATK/DRP1-MEDIATED MITOCHONDRIAL HOMEOSTASIS
por: Luo, Shiyuan, et al.
Publicado: (2023) -
Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
por: Baradaran-Heravi, Alireza, et al.
Publicado: (2016) -
A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation
por: Perez, Harvey, et al.
Publicado: (2021) -
Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015) -
Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021)